These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 9879288)

  • 101. Expression of prostate-specific antigen and human glandular kallikrein 2 in the thyroid gland.
    Magklara A; Cheung CC; Asa SL; Diamandis EP
    Clin Chim Acta; 2000 Oct; 300(1-2):171-80. PubMed ID: 10958873
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer.
    Deguchi T; Yang M; Ehara H; Ito S; Nishino Y; Takahashi Y; Ito Y; Shimokawa K; Tanaka T; Imaeda T; Doi T; Kawada Y
    Br J Cancer; 1997; 75(5):634-8. PubMed ID: 9043017
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Clinical usefulness of RT-PCR detection of hematogenous prostate cancer spread.
    Verkaik NS; Schröder FH; Romijn JC
    Urol Res; 1997; 25(6):373-84. PubMed ID: 9443645
    [TBL] [Abstract][Full Text] [Related]  

  • 104. [Conditions for the development of a program of reverse transcriptase-polymerase chain reaction for molecular staging of prostatic cancer].
    Llanes González L; Ferruelo Alonso A; Páez Borda A; Cabezas Martínez MA; Luján Galán M; Berenguer Sánchez A
    Actas Urol Esp; 2000 Apr; 24(4):287-92. PubMed ID: 14964086
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Frequency of expression of prostate-specific antigen mRNA in lung tumors.
    Zarghami N; Levesque M; D'Costa M; Angelopoulou K; Diamandis EP
    Am J Clin Pathol; 1997 Aug; 108(2):184-90. PubMed ID: 9260759
    [TBL] [Abstract][Full Text] [Related]  

  • 106. A comparative analysis of prostate-specific antigen gene sequence in benign and malignant prostate tissue.
    Baffa R; Moreno JG; Monne M; Veronese ML; Gomella LG
    Urology; 1996 Jun; 47(6):795-800. PubMed ID: 8677566
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice.
    Schmithals C; Kakoschky B; Denk D; von Harten M; Klug JH; Hintermann E; Dropmann A; Hamza E; Jacomin AC; Marquardt JU; Zeuzem S; Schirmacher P; Herrmann E; Christen U; Vogl TJ; Waidmann O; Dooley S; Finkelmeier F; Piiper A
    EBioMedicine; 2024 Jul; 105():105178. PubMed ID: 38889481
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay.
    Bilchik A; Miyashiro M; Kelley M; Kuo C; Fujiwara Y; Nakamori S; Monden M; Hoon DS
    Cancer; 2000 Mar; 88(5):1037-44. PubMed ID: 10699892
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder.
    Li SM; Zhang ZT; Chan S; McLenan O; Dixon C; Taneja S; Lepor H; Sun TT; Wu XR
    J Urol; 1999 Sep; 162(3 Pt 1):931-5. PubMed ID: 10458411
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Simultaneous detection of circulating prostate specific antigen (PSA)-expressing and prostate specific membrane antigen (PSM)-expressing cells by a multiplex reverse transcriptase polymerase chain reaction (RT-PCR) assay.
    Price DK; Woodard WL; Teigland CM
    Urol Oncol; 1995; 1(6):226-33. PubMed ID: 21224123
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer.
    Souza MF; Kuasne H; Barros-Filho MC; Cilião HL; Marchi FA; Fuganti PE; Paschoal AR; Rogatto SR; Cólus IMS
    PLoS One; 2017; 12(9):e0184094. PubMed ID: 28910345
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma.
    Matsumura M; Shiratori Y; Niwa Y; Tanaka T; Ogura K; Okudaira T; Imamura M; Okano K; Shiina S; Omata M
    J Hepatol; 1999 Aug; 31(2):332-9. PubMed ID: 10453948
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Reverse transcriptase-polymerase chain reaction for prostate-specific antigen may be a prognostic indicator in breast cancer.
    Lehrer S; Terk M; Piccoli SP; Song HK; Lavagnini P; Luderer AA
    Br J Cancer; 1996 Sep; 74(6):871-3. PubMed ID: 8826851
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Intraoperative molecular detection of circulating tumor cells by reverse transcription-polymerase chain reaction in patients with biliary-pancreatic cancer is associated with hematogenous metastasis.
    Uchikura K; Takao S; Nakajo A; Miyazono F; Nakashima S; Tokuda K; Matsumoto M; Shinchi H; Natsugoe S; Aikou T
    Ann Surg Oncol; 2002 May; 9(4):364-70. PubMed ID: 11986188
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.
    Burchill SA; Bradbury MF; Pittman K; Southgate J; Smith B; Selby P
    Br J Cancer; 1995 Feb; 71(2):278-81. PubMed ID: 7530983
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen.
    Loric S; Dumas F; Eschwege P; Blanchet P; Benoit G; Jardin A; Lacour B
    Clin Chem; 1995 Dec; 41(12 Pt 1):1698-704. PubMed ID: 7497608
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Molecular prediction of progression in patients with conservatively managed prostate cancer.
    McIntyre IG; Clarke RB; Anderson E; Clarke NW; George NJ
    Urology; 2001 Nov; 58(5):762-6. PubMed ID: 11711356
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Measurement of blood E2F3 mRNA in prostate cancer by quantitative RT-PCR: a preliminary study.
    Pipinikas CP; Nair SB; Kirby RS; Carter ND; Fenske CD
    Biomarkers; 2007; 12(5):541-57. PubMed ID: 17701752
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Prostate-specific antigen in acute hepatitis and hepatocellular carcinoma.
    Malavaud B; Miédougé M; Payen JL; Izopet J; Rischmann P; Pascal JP; Sarramon JP; Serre G
    Prostate; 1999 Dec; 41(4):258-62. PubMed ID: 10544299
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Identification by a Digital Gene Expression Displayer (DGED) and test by RT-PCR analysis of new mRNA candidate markers for colorectal cancer in peripheral blood.
    Lauriola M; Ugolini G; Rosati G; Zanotti S; Montroni I; Manaresi A; Zattoni D; Rivetti S; Mattei G; Coppola D; Strippoli P; Taffurelli M; Solmi R
    Int J Oncol; 2010 Aug; 37(2):519-25. PubMed ID: 20596680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.